Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agreed Drum,,,He just has to hit a send button,,,but when?
Looks like selling is done for now, VNDM did what he wanted and now he should (will) back off. I just cant understand why the selling. I guess they were just here for a nice run up and when the MM began taking it down, the faint of heart got frightened that they wouldn't have Christmas money and hit the sell button. Now, they will have to chase (IMO) as the MM has moved on.
I agree Mary and Kahan,,,I would be extremely disappointed should he release a PR once the markets close today. Surely he has learned that lesson. I wouldn't mind a nice juicy PR around 3:30 - 3:45 today though. It would be a nice Thanksgiving treat and would continue to propel the PPS into Friday.
Good post uba22me! Just watch what happens! The PPS has been coiling, large sales have been made, the MM's took this down so far today --- Now sit back and watch what happens! LOL
Yes, however it's from when the agreement has been squared.
Nice upward movement now
ub22me,,There is no hype here. Do your DD on the CEO and what has transpired at ONCI since his arrival!
MAZAR'S SELECTION ---Just in case any of you have doubts about MAZAR'S --- from the Marzar's web-page (I am sure this has been shown over and over but keeps coming up)
tel:1-888-992-3836
On4 Communications Selects Mazars USA LLP to Audit 2017 and All
Financials Moving Forward
NEW YORK, NY -- (Marketwired) -- 10/05/17 -- On4 Communications
(OTC: ONCI) today announced it has interviewed 2 audit firms in New
York, and decided to select Mazars USA LLP.
CEO Steve Berman comments, "It has always been my goal to have fully
audited financials and we are close to that goal today. I chose
Mazars LLP because of their expertise in foreign accounting as we are
now a global company. I will post the engagement letter on Twitter
later this afternoon. Audit expected to last 6 to 8 weeks. Upon
completion all requirements for OTCQB will be met, and maintaining a
.01 bid price would be all that remains."
"We would also like to announce that we have signed a contract with a
northern Florida auto group with 6 dealerships including Chevy, Kia,
Hyundai, Ford, Nissan and Toyota. Each dealership will take 20 units
per month at $200 per unit for a grand total of $288,000 per year."
"We are also pleased to announce that we have entered into a contract
with a large southwestern extended warranty company; we will be
selling their products which include extended warranties, tire and
wheel and other aftermarket products in our dealer network and they
will be selling our apps in their dealer network. They will start
with 50 units per month at $200 per unit and a grand total of
$120,000 per year."
"In addition, I will be travelling back to Kuala Lumpur on October
23rd for meetings with Malaysian cell phone companies, with the hope
of selling our apps at their retail locations. There are over 600
retail locations in Malaysia. I will also be meeting with our
attorney in Asia regarding finalization on the first manufacturing
facility which is expected by November 30, 2017. This acquisition
will be financed with a loan against receivables."
"The 3rd reduction of the share structure is as follows: I am owed a
bonus of 150 million shares for my work in 2016 and 2017. I will not
be taking this bonus and the 150 million shares will not be added to
our share structure. I will not be taking any bonuses going forward
as I want to have as much cash available for operations, and my
compensation package for 2018 is being reviewed by the board to
reflect these changes."
Berman adds, "I would also like to announce that we will have a
shareholder conference call on November 10, 2017, time and dial in
number will be announced shortly."
"Additional revenue contracts coming next week, and working on M&A
with an update expected within 2 weeks," CEO Steve Berman concludes.
About On4 Communications
On4 is a holdings company with an aggressive focus of acquiring
proven and profitable businesses. Our first project is focusing on
businesses operating in the $1.7 trillion U.S. healthcare industry.
Our newest targeted businesses are operating in the trillion-dollar
mobile App space. Our first acquisition in the mobile App space is
FMS Marketing a global creator and distributor of mobile Apps for
Android and iPhones. We are also targeting businesses to acquire and
joint venture with in the medical marijuana and emerging MJ ancillary
products space.
Forward-Looking Statement
This release includes forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. All
statements regarding our expected future financial position, results
of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities,
plans and objectives of management for future operations, as well as
statements that include words such as "anticipate," "if," \"believe,"
"plan," "estimate," "expect," "intend," "may," "could," "should,"
"will," and other similar expressions are forward-looking statements.
All forward-looking statements involve risks, uncertainties and
contingencies, many of which are beyond our control, which may cause
actual results, performance, or achievements, as described in our
reports filed with the Securities and Exchange Commission which are
available for review at www.sec.gov, to differ materially from
anticipated results, performance, or achievements. We are under no
obligation to (and expressly disclaim any such obligation to) update
or alter our forward-looking statements, whether as a result of new
information, future events or otherwise.
On4 Communications, Inc.
On4Company@gmail.com
(323) 487-0389
At the end of that video, it read "will be available sometime in 2018". I agree it's not competitive to what Steve and crew are out selling.
This app will not be available until sometime in 2018. This is why Steve is busting his ass to get out ahead of every knock-off.
$43 a share? No, not that much,,,yet!!
I can tell you that I don't mind if the CEO cracked,,I have been suspended twice for saying the same, although I did go a little further!
Yep,,,and just the start. GO ONCI!!!
Thanks for this. Looking for the finale!!
The CEO didn't say quite enough in my opinion! It had to be a hacked though. Like someone from on this site!!!HHMMMM, just too many possibilities to narrow it down to the top 100 posters here.
Fare thee well ENUM...
Enumeral Reports Second Quarter Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 14, 2017-- Enumeral Biomedical Holdings, Inc. (OTCQB: ENUM) (“Enumeral” or the “Company”) today announced its financial results for the three months ended June 30, 2017.
On June 29, 2017, the Company’s Board of Directors, having evaluated and pursued a range of potential strategic transactions, and other alternatives for the sale or disposition of its assets on a going concern basis, determined that it is in the best interests of the Company’s stockholders and creditors to wind down the Company’s remaining operations and effect an orderly disposition of the Company’s remaining assets, including the Company’s intellectual property related to its PD-1 and TIM-3 antibody programs.
Second Quarter 2017 Financial Results
Cash and Cash Equivalents: Cash and cash equivalents as of June 30, 2017 were $576,307, compared to $3,162,400 as of December 31, 2016. As of the date of this press release, Enumeral does not have sufficient cash resources to continue to fund its operations and pay all of its outstanding creditors. Enumeral is currently in the process of winding down its operations, disposing of its remaining assets, and resolving its outstanding debts. The Company’s liquidity is dependent on its ability to manage all elements of this process in a manner favorable to Enumeral. As the Company winds down its operations, it continues to consider possible transactions pursuant to which Enumeral may sell its remaining assets, and/or effect a strategic transaction, such as a merger. If Enumeral is unable to effect one or more such transactions, the Company may be compelled to commence liquidation or bankruptcy proceedings.
Revenue: Revenue decreased by $1,309,231 to $189,741 for the three months ended June 30, 2017, as compared to $1,498,972 for the three months ended June 30, 2016. This decrease in revenue is primarily attributable to the Company’s license agreement with Pieris Pharmaceuticals and its study agreement with Merck. As a result of the Company’s determinations in June 2017 to terminate its research and development function and sell its laboratory equipment, as well as to wind down its remaining operations, the Company does not expect to conduct any further activities pursuant to its study agreement with Merck. Consequently, the Company does not expect to recognize any additional revenue with respect to the Merck agreement.
Research and Development Expenses: Research and development expenses decreased by $357,463 to $883,338 for the three months ended June 30, 2017, as compared to $1,240,801 for the three months ended June 30, 2016. This decrease is primarily due to a decrease in payroll and personnel expenses as a result of lower headcount, a decrease in royalties owed to the Massachusetts Institute of Technology, a decrease in stock-based compensation, and a decrease in depreciation expense. As a result of the Company’s determinations in June 2017 to terminate its research and development function and sell its laboratory equipment, as well as to wind down its remaining operations and dispose of its remaining assets, the Company does not expect to incur significant research and development expenses in the future.
General and Administrative Expenses: General and administrative expenses decreased by $1,135,826 to $609,378 for the three months ended June 30, 2017, as compared to $1,745,204 for the three months ended June 30, 2016. This decrease is primarily due to a decrease in payroll and personnel expenses as a result of lower headcount, a decrease in professional fees, and a decrease in stock-based compensation. As a result of the Company’s determination in June 2017 to wind down its remaining operations, the Company expects that its general and administrative expenses will continue to decrease in the future.
Wind Down Expenses. Wind down expenses were $1,055,246 for the three months ended June 30, 2017. The Company recognized no wind down expenses for the three months ended June 30, 2016. The Company’s wind down expenses were primarily associated with the extinguishment of restricted cash in connection with the Company’s operating lease, a loss on the auction sale of its laboratory equipment, and a loss associated with the buyout of its equipment lease during the three months ended June 30, 2017.
Other Income (Expense): Other income (expense) changed by $919,849 to ($780,373) for the three months ended June 30, 2017, as compared to $139,476 for the three months ended June 30, 2016. This change is primarily due to a decrease in non-cash income related to the change in the fair value of derivative liabilities associated with the warrants issued in connection with the Company’s July 2014 private placement transaction, and an increase in interest expense resulting from the full accretion of the discount and other transaction costs associated with the Company’s Unit Offering in May 2017. In connection with the completion of the Company’s warrant tender offer on December 12, 2016, the July 2014 warrants were either exercised or amended to remove the anti-dilution provisions. As a result, these warrants are no longer classified as derivative liabilities.
Net Loss: Net loss increased by $1,791,037 to $3,138,594 for the three months ended June 30, 2017, as compared to $1,347,557 for the three months ended June 30, 2016.
Forward Looking Statements Disclosure
This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such statements reflect current beliefs of Enumeral Biomedical Holdings, Inc. (“Enumeral” or the “Company”) with respect to future events and involve known and unknown risks, uncertainties, and other factors affecting operations, market growth, Enumeral’s stock price, services, products and licenses. No assurances can be given regarding the achievement of future results, and although Enumeral believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, actual results may differ from the assumptions underlying the statements that have been made regarding anticipated events. Factors that may cause actual results, performance or achievements, or industry results to differ materially from those contemplated by such forward-looking statements may include, without limitation, (a) Enumeral’s ability to wind down its operations, dispose of its remaining assets, and resolve its outstanding debts, as well as cash flows and resulting liquidity, (b) Enumeral’s expectations regarding market acceptance of the Company’s business in general and the Company’s ability to penetrate the antibody discovery and development fields in particular, as well as the timing of such acceptance, (c) Enumeral’s ability to attract and retain management with experience in biotechnology and antibody discovery and similar emerging technologies, (d) Enumeral’s ability to partner with other companies to bring product candidates through the development stage and eventually to market, (e) the scope, validity and enforceability of Enumeral’s and third party intellectual property rights, (f) Enumeral’s ability to comply with governmental regulation, (g) the intensity of competition, (h) changes in the political and regulatory environment and in business and fiscal conditions in the United States and overseas, and (i) general economic conditions.
More detailed information about Enumeral and risk factors that may affect the realization of forward-looking statements, including forward-looking statements in this press release, is set forth in Enumeral’s filings with the Securities and Exchange Commission. Enumeral urges investors and security holders to read those documents free of charge at the Commission’s website at http://www.sec.gov. Forward-looking statements speak only as to the date they are made, and except for any obligation under the U.S. federal securities laws, Enumeral undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise.
Wow, down 40% on the sale of 1000 shares. Probably couldn't cover the broker fee.
I would have to believe this was a hacking incident. Although I certainly could understand the venom!!
Lovin' those tweets by our CEO. I wonder if,,,well never mind. His latest tweets are spot on!!!
No Sunday PR's.
Price Performance Comparison
Index Comparison
ONCI:OTC Pink - Current Information 11/17/2017
1 Month 6 Months 1 Year
+7.37% +1,357.14% +1,175.00%
[S&P 500
+0.92% +9.30% +18.77% Percentile : 95.7228944023351%
S&P Global BMI
+0.03% +7.36% +21.21% Percentile : 96.0397312688992%
It's good to be in a high performing stock. Why all the bitching?
That may be your investment strategy. Personally I am retired and have a nice monthly income stream to cover my bills, expenses and whatever I want. I put aside a separate account to play stocks with. It provides me with something to do during the day. When I started trading, I lost my ass. Then I learned what works for me.
I was lucky enough to find this particular investment back in early summer, late spring and have all the faith that this company will pay out more than a bank or mutual fund. This is a jewel in the OTC.
I haven't found a bank nor mutual fund which can provide me over 600% and IMO will continue to provide me a healthy investment going forward. But I do appreciate you worrying about my account and how I elect to invest. Thank you
Just relax
This is just the way it is:
OTC Pinks,,,gotta love it!!!
No, you can't,,,lol
It's been creeping up from the .0084 low. Up to .0090 and hopefully some buyers about to change this up.
Thanks for your help and I have a question. Have you ever followed the tickers which you post above it's 10 daily average? What I mean is when you post a ticker symbol exceeding its 10 day average, do you follow-up on how that stock has performed in say:
Day 1 == up 22%
Day 2 == up 32%
Day 3 == down 28%
Day 4 == down 27%
Day 5 == down 13%
I am curious how those companies might be performing in at least a 5 day or 10 day period once they show a volume increase of over 25% + in one day. If you have that, I would like to see it. If you don't track that type of information, would you mind if I used your data as a starting point so that I can track it?
Thanks Ockham's Razor
In my own opinion, QVC will be an exceptional venue to get the bSafemobile app out to the public. I really don't anticipate a huge revenue booster from the QVC deal as QVC sucks every possible penny from all of it's deals.
Steve would love to do the deal if only for name recognition and huge aftermarket sales which the show will produce.
yep, volume has dried up to a trickle. Maybe later people will take a look.
I don't know. If most golfers are like me, by around the 15th hole my cart seems to veer towards large trees or ponds. iPads aren't that tough.
Just kidding, great foresight!!
Nice increase. Needs the volume to flow in. 1/5 daily volume.
berdboy, Steve Berman does not OWE you anything. If he wanted to, he probably could snap a photo of himself in Dubia,,,then what's next,,,more and more people wanting him to prove something else. Bottom line is you want to stay long term or sell your shares. You can wait to buy back once you SEE the proof.
Well, I can't dispute your claim that Pinks are a tough market. We all know that. We have all been burned a few times. The sales, revenues and expenses will be available soon enough. We should know in about a month whether the PR's, news and Steve's tweets are real or not.
As you have pointed out, we are a Pink Sheet company in the OTC. This is one of the rare opportunities to find in a sea of scum, manipulations and lies.
The thing is this, you can hold or fold. I have elected to hold as I have seen what can happen to the PPS in 3 minutes. I like this hand and am pat!
Good luck!
Yep, I think the volume will be back. There is too much here for it not to happen. Institutions will bring this pps up. IMO
birdboy, I don't take your comments as bashing or hating. Sometimes, actually many times, impatience takes a toll for someone who wants something so bad they turn angry and begin to blame those whom they believe is not doing enough so "you" can realise YOUR goal.
Steve Berman is not lying or deceiving us in any way. He is working as hard as he can to make Hexagon Holdings a top notch company. Whether you believe or not, it's happening. FINRA will be finalized very soon and we will have the name and ticker symbol change. We will be re-domiciled. We will continue to watch as Steve and the gang mount up huge weekly revenues. We all have to wait for the FINS to verify the sales. All of us.
While we wait for the Fins, we will watch the sales mount. Hexagon holdings will continue to grow as well as the PPS. Investors will come and go. Some many times as that's how some play the game. Many of us continue to believe that Steve has a vision for each arm of this company. Not only the vision but the energy to continue making Hexagon Holdings worth owning. There is no doubt in my mind this little OTC company will not only find its way out of Pinks and QT, but will survive well in NASDAQ. These things take time. The mountain is steep but we will see the top.
All of this is in my own opinion as that's all I have.
I agree, this needs to hold the 50ma.
$UHLN,, interesting
$VNTH,, needs just a little PR to get volume
IMHO,,,good luck trading,,,I still have faith in my position here!
$VNTH,,,check this out. With a little bit of volume or when CEO puts out news, this looks like it could soar,,,IMHO!
https://www.slideshare.net/slideshow/embed_code/key/exDYMhswlByqjK
From 2013,,,NASA invention of the year award.
https://www.spacefoundation.org/programs/space-certification/certified-products/space-technology/nanobeak-sensor